MedPath

HAVRIX - 720UNIT/ML SUS

HAVRIX - 720UNIT/ML SUS

Discontinued
DIN Number

02108216

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02108216
AIG Number0126318001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BC02 HEPATITIS A, INACTIVATED, WHOLE VIRUS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

HEPATITIS A VACCINE, INACTIVATEDActive
Strength: 720 UNIT / ML
Monograph: HEPATITIS A VACCINE, INACTIVATED

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.